EUVIMEDEUVIMED entdecken
Crossref

Otolaryngologic Side Effects After COVID ‐19 Vaccination

Salma Ahsanuddin iD, Ryan Jin iD, Aatin K Dhanda iD, Kirolos Georges iD, Soly Baredes, Jean Anderson Eloy iD, Christina H Fang iD

The Laryngoscope · 2024

DOI: 10.1002/lary.30923 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Laryngoscope, 2024. Verfasst von Salma Ahsanuddin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology - Head and Neck Surgery, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York, USA. Hauptthemen laut MEDLINE: Anaphylaxis, Bell Palsy, Facial Paralysis, COVID-19. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

With widespread vaccination against COVID‐19, concerns regarding side effects have been raised. We aim to assess the frequency of otolaryngologic adverse events (AEs) following COVID‐19 vaccination as compared with other vaccines in a national database. Study Design Retrospective analysis of national registry.

Methods

The Food and Drug Administration's Vaccine Adverse Event Reporting System (VAERS) database was queried from December 2020 to May 2021 for all COVID‐19 vaccination AEs. Complaints were categorized as otolaryngologic and sub stratified into different anatomic components. Reporting odds ratios (ROR) and proportional reporting ratios (PRR) were determined for AEs of clinical significance.

Results

The total number of AEs reported from vaccination with the Moderna, Pfizer‐BioNTech, and Janssen vaccines equaled 1,280,950. Of these, 62,660 (4.9%) were otolaryngologic in nature, with 32.6% associated with the oropharynx/larynx, 18.3% with the nasal cavity/sinuses, 17.1% with the ears/vestibular system, 10.0% with the oral cavity, and 21.9% miscellaneous. Signal ratios reached significance levels for dysgeusia ( n = 2124, PRR: 17.33, ROR: 16.36), ageusia ( n = 1376, PRR: 2.81, ROR: 2.81), anosmia ( n = 983, PRR: 4.01, ROR: 4.01), rhinorrhea ( n = 2203, PRR: 2.99, ROR: 3.00), throat tightness ( n = 3666, PRR: 4.99, ROR: 5.00), throat irritation ( n = 3313, PRR: 4.51, ROR: 4.52), dysphagia ( n = 2538, PRR: 2.07, ROR: 2.07), tinnitus ( n = 4377, PRR: 3.97, ROR: 3.98), and vertigo ( n = 2887, PRR: 3.93, ROR: 3.93). Signal ratios were not significant for facial paralysis, Bell's palsy, anaphylaxis, sinusitis, hearing disability, and ear pain.

Conclusions

Although several otolaryngologic symptoms were reported, few were found to be clinically significant. Of note, facial paralysis, Bell's palsy, and anaphylaxis did not meet signal thresholds to be determined significant. Level of Evidence 4 Laryngoscope , 134:1163–1168, 2024

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnaphylaxisBell PalsyFacial ParalysisCOVID-19VaccinesHumansCOVID-19 VaccinesPharynxRetrospective StudiesAdverse Drug Reaction Reporting SystemsVaccination

Stichwörter der Autor:innen

COVID-19adverse eventsotolaryngologypharmacovigilancevaccination

Substanzen

COVID-19 VaccinesVaccines

Autor:innen und Institutionen

  • Department of Otorhinolaryngology - Head and Neck Surgery, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York, USA.
  • Department of Otolaryngology-Head & Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
  • Center for Skull Base and Pituitary Surgery, Neurological Institute of New Jersey, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
  • Department of Neurological Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
  • Department of Ophthalmology and Visual Science, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
  • Department of Otolaryngology and Facial Plastic Surgery, Saint Barnabas Medical Center, RWJBarnabas Health, Livingston, New Jersey, USA.

ORCID-Profile: Salma Ahsanuddin, Ryan Jin, Aatin K Dhanda, Kirolos Georges, Jean Anderson Eloy, Christina H Fang

Zitieren

APA

Ahsanuddin, S., Jin, R., Dhanda, A. K., Georges, K., Baredes, S., Eloy, J. A., & Fang, C. H. (2024). Otolaryngologic Side Effects After COVID ‐19 Vaccination. The Laryngoscope. https://doi.org/10.1002/lary.30923

Vancouver

Ahsanuddin S, Jin R, Dhanda AK, Georges K, Baredes S, Eloy JA, et al. Otolaryngologic Side Effects After COVID ‐19 Vaccination. The Laryngoscope. 2024. doi:10.1002/lary.30923

BibTeX
@article{Ahsanuddin2024,
  author = {Ahsanuddin, Salma and Jin, Ryan and Dhanda, Aatin K and Georges, Kirolos and Baredes, Soly and Eloy, Jean Anderson and Fang, Christina H},
  title = {Otolaryngologic Side Effects After COVID ‐19 Vaccination},
  journal = {The Laryngoscope},
  year = {2024},
  doi = {10.1002/lary.30923}
}
Kostenlos starten →